Drug-coated balloon-only percutaneous coronary intervention for the treatment of De novo coronary artery disease: a systematic review
File(s) Mohiaddin et al DCB 2018 paper.pdf (594.27 KB)
Published version
Author(s)
Mohiaddin, Hasan
Wong, Tamar DFK
Burke-Gaffney, Anne
Bogle, Richard G
Type
Journal Article
Abstract
Percutaneous coronary intervention (PCI) with a drug coated balloon (DCB) is a novel treatment which seeks to acutely dilate a coronary stenosis and deliver an anti-proliferative drug to the vessel wall (reducing the risk of re-stenosis), without implanting a drug eluting stent (DES). In this study, we performed a systematic review of stentless DCB-only angioplasty in de novo coronary artery disease. We identified 41 studies examining the effects of DCB-only PCI in a variety of clinical scenarios including small vessels, bifurcations, calcified lesions, and primary PCI. DCB-only PCI appears to be associated with comparable clinical outcomes to DESs and superior angiographic outcomes to plain-old balloon angioplasty. Although current data are promising, there is still a need for further long-term randomized control trial data comparing a DCB-only approach specifically against a second- or third-generation DES. A 4-week period of dual antiplatelet therapy provides a real advantage for the DCB-only PCI approach, which is not possible with most DESs. Since rates of adverse clinical outcomes are very low for all PCI procedures attention should be turned to the development of robust endpoints with which to compare DCB-only PCI approaches to the standard treatment with a DES.
Date Issued
2018-12-01
Date Acceptance
2018-09-04
Citation
Cardiology and Therapy, 2018, 7 (2), pp.127-149
ISSN
2193-6544
Publisher
Springer Verlag
Start Page
127
End Page
149
Journal / Book Title
Cardiology and Therapy
Volume
7
Issue
2
Copyright Statement
© 2018 The Author(s). Open Access. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/30368735
PII: 10.1007/s40119-018-0121-2
Subjects
Coronary artery disease
De novo
Drug-coated balloon
Drug-eluting balloon
Percutaneous coronary intervention
Publication Status
Published
Coverage Spatial
England
Date Publish Online
2018-10-27
